Precise ADC Drug Discovery & Development From Bench to Bedside
- Outlining how advanced computational methods and high-throughput screening of omics data are used to precisely identify and validate novel targets for antibody-drug conjugates, ensuring a strong scientific rationale from the outset
- Discussing the crucial role of patient-derived xenografts and patient-derived organoids in evaluating ADC efficacy and safety
- Detailing the process of translating a successful ADC candidate into a clinical setting